Westchester Capital Management (New York)’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Westchester Capital Management (New York)’s Portfolio MSACW Stock Details MSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,554	Closed	-$2.34K	–	496
2022 Q4	$2.34K	Hold	26,554	–	–	﹤0.01%	424
2022 Q3	$1K	Hold	26,554	–	–	﹤0.01%	473
2022 Q2	$4K	Hold	26,554	–	–	﹤0.01%	424
2022 Q1	$11K	Hold	26,554	–	–	﹤0.01%	414
2021 Q4	$19K	Hold	26,554	–	–	﹤0.01%	385
2021 Q3	$19K	Hold	26,554	–	–	﹤0.01%	357
2021 Q2	$27K	Buy	+26,554	New	+$21K	﹤0.01%	324

Westchester Capital Management (New York)'s MSACW Position: Q1 2023 in Review

Westchester Capital Management (New York) sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q1 2023, closing a stake of 26,554 shares — an estimated $2.34K sold.

Westchester Capital Management (New York) first reported a position in MSACW in Q2 2021 and held it in 7 quarters. The position peaked at $27K in Q2 2021. 0 funds tracked by Wall St. Rank hold MSACW as of Q1 2023.

Westchester Capital Management (New York) reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 26,554 Medicus Sciences Acquisition Corp. Warrant shares in Q1 2023, an estimated $2.34K.
Westchester Capital Management (New York) first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
Westchester Capital Management (New York)'s Medicus Sciences Acquisition Corp. Warrant position peaked at $27K in Q2 2021.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q1 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2023, filed 15 May 2023.